<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 201905//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title>Antibiotics</journal-title></journal-title-group><issn pub-type="epub">2079-6382</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8156192</article-id><article-id pub-id-type="doi">10.3390/antibiotics10050592</article-id><article-id pub-id-type="publisher-id">antibiotics-10-00592</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antifungal and Anti-Inflammatory Potential of <italic>Bupleurum rigidum</italic> subsp. <italic>paniculatum</italic> (Brot.) H.Wolff Essential Oil</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zuzarte</surname><given-names>M&#x000f3;nica</given-names></name><xref ref-type="aff" rid="af1-antibiotics-10-00592">1</xref><xref ref-type="aff" rid="af2-antibiotics-10-00592">2</xref><xref ref-type="aff" rid="af3-antibiotics-10-00592">3</xref><xref rid="c1-antibiotics-10-00592" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2692-7691</contrib-id><name><surname>Correia</surname><given-names>Pedro M. P.</given-names></name><xref ref-type="aff" rid="af4-antibiotics-10-00592">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5270-3993</contrib-id><name><surname>Alves-Silva</surname><given-names>Jorge M.</given-names></name><xref ref-type="aff" rid="af1-antibiotics-10-00592">1</xref><xref ref-type="aff" rid="af2-antibiotics-10-00592">2</xref><xref ref-type="aff" rid="af3-antibiotics-10-00592">3</xref><xref ref-type="aff" rid="af5-antibiotics-10-00592">5</xref></contrib><contrib contrib-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>Maria J.</given-names></name><xref ref-type="aff" rid="af5-antibiotics-10-00592">5</xref><xref ref-type="aff" rid="af6-antibiotics-10-00592">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5937-1127</contrib-id><name><surname>Cavaleiro</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="af5-antibiotics-10-00592">5</xref><xref ref-type="aff" rid="af6-antibiotics-10-00592">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9846-6754</contrib-id><name><surname>Cruz</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="af5-antibiotics-10-00592">5</xref><xref ref-type="aff" rid="af7-antibiotics-10-00592">7</xref></contrib><contrib contrib-type="author"><name><surname>Salgueiro</surname><given-names>L&#x000ed;gia</given-names></name><xref ref-type="aff" rid="af5-antibiotics-10-00592">5</xref><xref ref-type="aff" rid="af6-antibiotics-10-00592">6</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Sabia</surname><given-names>Carla</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Iseppi</surname><given-names>Ramona</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-antibiotics-10-00592"><label>1</label>Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, 3000-548 Coimbra, Portugal; <email>jmasilva@student.ff.uc.pt</email></aff><aff id="af2-antibiotics-10-00592"><label>2</label>Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal</aff><aff id="af3-antibiotics-10-00592"><label>3</label>Clinical Academic Centre of Coimbra (CACC), 3000-548 Coimbra, Portugal</aff><aff id="af4-antibiotics-10-00592"><label>4</label>Faculty of Sciences, BioISI&#x02014;Biosystems &#x00026; Integrative Sciences Institute, University of Lisboa, 1749-016 Lisboa, Portugal; <email>pmpcorreia@fc.ul.pt</email></aff><aff id="af5-antibiotics-10-00592"><label>5</label>Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; <email>mpinho@ff.uc.pt</email> (M.J.G.); <email>cavaleir@ff.uc.pt</email> (C.C.); <email>trosete@ff.uc.pt</email> (T.C.); <email>ligia@ff.uc.pt</email> (L.S.)</aff><aff id="af6-antibiotics-10-00592"><label>6</label>Chemical Process Engineering and Forest Products Research Centre (CIEPQPF), Department of Chemical Engineering, University of Coimbra, 3030-790 Coimbra, Portugal</aff><aff id="af7-antibiotics-10-00592"><label>7</label>Centre for Neuroscience and Cell Biology (CNC), 3000-548 Coimbra, Portugal</aff><author-notes><corresp id="c1-antibiotics-10-00592"><label>*</label>Correspondence: <email>mzuzarte@uc.pt</email></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>5</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2021</year></pub-date><volume>10</volume><issue>5</issue><elocation-id>592</elocation-id><history><date date-type="received"><day>02</day><month>4</month><year>2021</year></date><date date-type="accepted"><day>07</day><month>5</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Fungal infections remain a major health concern with aromatic plants and their metabolites standing out as promising antifungal agents. The present study aims to assess, for the first time, the antifungal and anti-inflammatory potential of <italic>Bupleurum</italic> subsp. <italic>paniculatum</italic> (Brot.) H.Wolff essential oil from Portugal. The oil obtained by hydrodistillation and characterized by GC-MS, showed high amounts of monoterpene hydrocarbons, namely &#x003b1;-pinene (29.0&#x02013;36.0%), &#x003b2;&#x02013;pinene (26.1&#x02013;30.7%) and limonene (10.5&#x02013;13.5%). The antifungal potential was assessed, according to CLSI guidelines, against several clinical and collection strains. The essential oil showed a broad fungicidal effect being more potent against <italic>Cryptococcus neoformans</italic> and dermatophytes. Moreover, a significant germ tube inhibition was observed in <italic>Candida albicans</italic> as well as a disruption of mature biofilms, thus pointing out an effect of the oil against relevant virulent factors. Furthermore, fungal ultrastructural modifications were detected through transmission electron microscopy, highlighting the nefarious effect of the oil. Of relevance, the oil also evidenced anti-inflammatory activity through nitric oxide inhibition in macrophages activated with lipopolysaccharide. In addition, the essential oil&#x02019;s bioactive concentrations did not present toxicity towards macrophages. Overall, the present study confirmed the bioactive potential of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> essential oil, thus paving the way for the development of effective drugs presenting concomitantly antifungal and anti-inflammatory properties.</p></abstract><kwd-group><kwd>antifungal</kwd><kwd>germ tube</kwd><kwd>biofilm</kwd><kwd>anti-inflammatory</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-antibiotics-10-00592"><title>1. Introduction</title><p>Fungal infections account for nearly 1.6 million deaths worldwide, thus presenting a huge socio-economic burden, frequently neglected by public health authorities [<xref rid="B1-antibiotics-10-00592" ref-type="bibr">1</xref>]. Most fungal infections affect mucous membranes, especially vaginal and mouth membranes [<xref rid="B2-antibiotics-10-00592" ref-type="bibr">2</xref>] and, despite being primarily superficial, mycosis can rapidly evolve into systemic infections, especially in immunocompromised individuals. These type of infections are mainly caused by <italic>Candida albicans</italic>, nevertheless other <italic>Candida</italic> species are becoming important etiological agents such as <italic>C. krusei</italic>, <italic>C. parapsilosis</italic> and <italic>C. tropicalis</italic> [<xref rid="B3-antibiotics-10-00592" ref-type="bibr">3</xref>]. Several features contribute to <italic>Candida</italic> spp. virulence including yeast-to-hypha morphological transition and biofilm formation [<xref rid="B4-antibiotics-10-00592" ref-type="bibr">4</xref>]. The first, starts with germ tube formation that develop into hypha promoting tissue penetration and immune avoidance, thus resulting in a more effective infection. In addition, this transition is necessary for biofilm formation [<xref rid="B5-antibiotics-10-00592" ref-type="bibr">5</xref>]. These complex structures can be formed in both biological and artificial surfaces and constitute a major clinical burden due to their higher resistance to antifungal drugs [<xref rid="B6-antibiotics-10-00592" ref-type="bibr">6</xref>]. In fact, for most conventional antifungals, the minimal inhibitory concentration necessary to inhibit biofilms is 100-fold higher than the concentrations needed to inhibit planktonic cells [<xref rid="B7-antibiotics-10-00592" ref-type="bibr">7</xref>]. Fungal infections can also be caused by other yeast such as <italic>Cryptococcus neoformans</italic> which affects the central nervous system and by dermatophytes of the <italic>Trichophyton</italic>, <italic>Microsporum</italic> and <italic>Epidermophyton</italic> genera. Dermatophytes are able to colonize keratinized structures, such as hair, skin and nails. Furthermore, filamentous fungi from the <italic>Aspergillus</italic> genus, especially <italic>A. fumigatus</italic>, <italic>A. flavus</italic> and <italic>A. niger</italic>, are also important agents in the development of bloodstream systemic infections as well as pulmonary and allergic infections [<xref rid="B8-antibiotics-10-00592" ref-type="bibr">8</xref>].</p><p>Current antifungal therapy continues to present several limitations due to safety issues, pharmacokinetics, narrow activity spectrum and low number of targets [<xref rid="B9-antibiotics-10-00592" ref-type="bibr">9</xref>] For example, polyenes and amphotericin B are highly toxic whereas azoles, like fluconazole, only present a fungistatic effect. In addition, the emergence of resistant strains also compromises the effectiveness of these antifungals [<xref rid="B10-antibiotics-10-00592" ref-type="bibr">10</xref>,<xref rid="B11-antibiotics-10-00592" ref-type="bibr">11</xref>].</p><p>Importantly, fungal infections also trigger an inflammatory response when fungal epitopes such as zymosan, bind to toll-like receptors (TLRs) in the host cells. TLRs binding triggers a series of intracellular cascades that culminate with the activation of pro-inflammatory transcription factors as well as the expression of several inflammatory cytokines such as interleukin-1&#x003b2; (IL-1 &#x003b2;), IL-6 and TNF-&#x003b1;, which further fuel the inflammatory response [<xref rid="B12-antibiotics-10-00592" ref-type="bibr">12</xref>,<xref rid="B13-antibiotics-10-00592" ref-type="bibr">13</xref>]. In addition, TLRs binding also leads to the production of reactive oxygen and nitrogen species, such as nitric oxide [<xref rid="B14-antibiotics-10-00592" ref-type="bibr">14</xref>] due to an increase in the production of key pro-inflammatory enzymes, such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) [<xref rid="B15-antibiotics-10-00592" ref-type="bibr">15</xref>].</p><p>In some disorders such as gastrointestinal tract inflammatory diseases, like Chron&#x02019;s disease, the colonization by <italic>Candida</italic> spp. is promoted leading to an exacerbated production of inflammatory cytokines which further worsens the inflammatory condition [<xref rid="B16-antibiotics-10-00592" ref-type="bibr">16</xref>]. This triggers an endless circle of infection-inflammation that is generally controlled by the use of anti-inflammatory drugs. Nevertheless, these drugs have several side effects, including gastrointestinal, cardiovascular, hepatic, renal, cerebral and pulmonary complications [<xref rid="B17-antibiotics-10-00592" ref-type="bibr">17</xref>]. Therefore, the development of new antifungal and anti-inflammatory agents with less side effects is mandatory and compounds showing concomitantly both properties represent a valuable therapeutic strategy.</p><p>In this context, aromatic and medicinal plants, especially those belonging to the Lamiaceae and Apiaceae families, emerge as promising sources of antifungal and/or anti-inflammatory agents. Indeed, species from the Apiaceae family have been used for centuries in traditional medicine for the treatment of several pathologies. Their beneficial effects are often related to the presence of essential oils, with reported antifungal and anti-inflammatory properties [<xref rid="B18-antibiotics-10-00592" ref-type="bibr">18</xref>,<xref rid="B19-antibiotics-10-00592" ref-type="bibr">19</xref>]. However, many uses are based on empiric knowledge, and the spectrum of action as well as the underlying mechanisms of action remain unknown, thus justifying scientific-based studies to further contribute to the development of effective therapeutics.</p><p><italic>Bupleurum</italic> L. is one of the largest genus of the Apiaceae (Umbelliferae) family. Species from this genus are used in Asia, North Africa and Europe for their medicinal properties and have been used for millennia in traditional Chinese medicine [<xref rid="B20-antibiotics-10-00592" ref-type="bibr">20</xref>]. For example, in Spain these species are used for the treatment of topical inflammation, as anti-infective and to promote wound healing [<xref rid="B21-antibiotics-10-00592" ref-type="bibr">21</xref>], thus suggesting an antimicrobial and anti-inflammatory potential. Several secondary metabolites have also been described in <italic>Bupleurum</italic> species, including saikosaponins, flavonoids and volatile oils [<xref rid="B20-antibiotics-10-00592" ref-type="bibr">20</xref>]. Moreover, different studies have also shown their anti-inflammatory [<xref rid="B22-antibiotics-10-00592" ref-type="bibr">22</xref>,<xref rid="B23-antibiotics-10-00592" ref-type="bibr">23</xref>,<xref rid="B24-antibiotics-10-00592" ref-type="bibr">24</xref>]; hepatoprotection [<xref rid="B25-antibiotics-10-00592" ref-type="bibr">25</xref>,<xref rid="B26-antibiotics-10-00592" ref-type="bibr">26</xref>], antioxidant [<xref rid="B22-antibiotics-10-00592" ref-type="bibr">22</xref>,<xref rid="B27-antibiotics-10-00592" ref-type="bibr">27</xref>,<xref rid="B28-antibiotics-10-00592" ref-type="bibr">28</xref>], antifungal and antibacterial potential [<xref rid="B29-antibiotics-10-00592" ref-type="bibr">29</xref>,<xref rid="B30-antibiotics-10-00592" ref-type="bibr">30</xref>]. In addition, a patent for the use of <italic>B. fruticosum</italic> essential oil as an anti-ageing agent has been filled by L&#x02019;Or&#x000e9;al [<xref rid="B31-antibiotics-10-00592" ref-type="bibr">31</xref>], thus reinforcing the industrial and pharmaceutical interest of this genus.</p><p>Among <italic>Bupleurum</italic> species, <italic>B. rigidum</italic> L. is one of the most widely represented in Portugal. This species is widely used in Spain for the treatment of topical inflammation, as anti-diarrheic and against furuncles [<xref rid="B21-antibiotics-10-00592" ref-type="bibr">21</xref>]. Two subspecies of <italic>B. rigidum</italic> have been described, namely subsp. <italic>paniculatum</italic> and subsp. <italic>rigidum</italic>. <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> (Brot.) H.Wolff is an endemic species to the south and center of Portugal, Andaluc&#x000ed;a (Spain) and North Africa [<xref rid="B32-antibiotics-10-00592" ref-type="bibr">32</xref>] and, up to date, no studies on this subspecies have been conducted. Therefore, and as part of our ongoing studies on the valorization of wild Apiaceae species, we aim to characterize the essential oil composition of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> from Portugal and assess its bioactive potential. A combined antifungal and anti-inflammatory potential for <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> essential oil is reported, with emphasis on its effect against <italic>C. albicans</italic> virulence factors.</p></sec><sec sec-type="results" id="sec2-antibiotics-10-00592"><title>2. Results</title><sec id="sec2dot1-antibiotics-10-00592"><title>2.1. Essential Oil Composition</title><p><xref rid="antibiotics-10-00592-t001" ref-type="table">Table 1</xref> summarizes the chemical profile of two samples of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> analyzed by GC-MS. A yield of 0.7% (<italic>w</italic>/<italic>v</italic>) was obtained for the essential oil from Coimbra and 0.6% for the oil from F&#x000e1;tima. More than 95% of the compounds were identified in both samples.</p><p>The chemical analysis showed that both essential oils are characterized by the presence of high amounts of monoterpene hydrocarbons (94.4&#x02013;96.6%), mainly &#x003b1;-pinene (29.0&#x02013;36.0%), &#x003b2;-pinene (26.1&#x02013;30.7%) and limonene (10.5&#x02013;13.5%). The essential oil from Coimbra region represents a much larger population and, therefore, was selected to assess the antifungal and anti-inflammatory potential of the oil.</p></sec><sec id="sec2dot2-antibiotics-10-00592"><title>2.2. Antifungal Activity</title><sec id="sec2dot2dot1-antibiotics-10-00592"><title>2.2.1. The Essential Oil Showed a Broad-Spectrum Fungicidal Effect</title><p>The antifungal potential of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> essential oil was assessed against several yeast, dermatophyte and <italic>Aspergillus</italic> strains as depicted in <xref rid="antibiotics-10-00592-t002" ref-type="table">Table 2</xref>. Besides collection strains, fungal isolates obtained from the clinic were also assessed, thus providing data on the antifungal potential of the oil against more resistant strains. Overall, the essential oil showed a significant antifungal effect against <italic>Cryptococcus neoformans</italic> and <italic>Trichophytum rubrum</italic> with MIC values of 72 &#x000b5;g/mL (<xref rid="antibiotics-10-00592-t002" ref-type="table">Table 2</xref>). For the remaining dermatophytes, the oil was also effective with MIC values ranging from 144 &#x000b5;g/mL to 288 &#x000b5;g/mL. In addition, relevant antifungal effects were observed for <italic>Aspergillus</italic> and the majority of <italic>Candida</italic> strains (<xref rid="antibiotics-10-00592-t002" ref-type="table">Table 2</xref>). Interestingly for the majority of the tested stains, the oil showed similar MIC and MLC values, thus presenting a fungicidal effect (<xref rid="antibiotics-10-00592-t002" ref-type="table">Table 2</xref>). This is quite relevant since azoles, namely flucanozole, an antifungal drug widely used in the clinic, shows primarily fungistatic effects. Indeed, this antifungal drug, for the majority of the tested strains, is able to inhibit fungal growth but at the MIC it is not lethal to the fungi.</p></sec><sec id="sec2dot2dot2-antibiotics-10-00592"><title>2.2.2. The Essential Oil was Effective against <italic>Candida albicans</italic> Virulent Factors</title><p><italic>Candida albicans</italic> is able to switch from yeast-to-hypha morphology promoting tissue invasiveness [<xref rid="B33-antibiotics-10-00592" ref-type="bibr">33</xref>] and to form biofilms, an organized structure more resistant to antifungal agents than planktonic fungi [<xref rid="B34-antibiotics-10-00592" ref-type="bibr">34</xref>]. These features play a pivotal role in <italic>C. albicans</italic> pathogenesis and virulence, thus constituting promising therapeutic targets. Therefore, the present study aimed to assess the effect of the essential oil on both features (<xref ref-type="fig" rid="antibiotics-10-00592-f001">Figure 1</xref> and <xref ref-type="fig" rid="antibiotics-10-00592-f002">Figure 2</xref>). As shown in <xref ref-type="fig" rid="antibiotics-10-00592-f001">Figure 1</xref>, the essential oil strongly inhibited germ tube formation in <italic>C. albicans</italic> at concentrations well below its respective MIC. Interestingly, at concentrations as low as MIC/8 (72 &#x003bc;g/mL) the oil inhibited germ tube formation by ca. 40% and at MIC/4 (144 &#x003bc;g/mL), 88% of inhibition was observed (<xref ref-type="fig" rid="antibiotics-10-00592-f001">Figure 1</xref>a). Fluconazole failed to accomplish this up to 200 &#x003bc;g/mL, as pointed out in <xref ref-type="fig" rid="antibiotics-10-00592-f001">Figure 1</xref>b, thus highlighting the relevance of our results. </p><p>The capacity of the essential oil to decrease biofilm mass and biofilm viabilitywas also tested as well as that of fluconazole (<xref ref-type="fig" rid="antibiotics-10-00592-f002">Figure 2</xref>). Overall, the oil was effective and decreased biofilm viability at concentrations similar to the respective MIC and at a slightly higher concentration, the oil also disrupted mature biofilms (<xref ref-type="fig" rid="antibiotics-10-00592-f002">Figure 2</xref>a). Fluconazole, on the other hand, was only effective in decreasing <italic>C. albicans</italic> viability at a much higher concentration than its respective MIC and was ineffective in reducing biofilm mass even at concentration 200&#x000d7; higher than its MIC, as shown in <xref ref-type="fig" rid="antibiotics-10-00592-f002">Figure 2</xref>b.</p></sec><sec id="sec2dot2dot3-antibiotics-10-00592"><title>2.2.3. The Essential Oil Modified the Ultrastructure of <italic>Candida albicans</italic> and <italic>Trichophyton rubrum</italic></title><p>Bearing in mind the promising fungicidal effect observed against <italic>T. rubrum</italic> as well as the inhibition of virulence factors registered in <italic>C. albicans</italic>, both strains were selected to further elucidate the effect of the essential oil at an ultrastructural level. For this, transmission electron microscopy analysis were performed. <xref ref-type="fig" rid="antibiotics-10-00592-f003">Figure 3</xref> and <xref ref-type="fig" rid="antibiotics-10-00592-f004">Figure 4</xref> compile representative images of the alterations observed in <italic>C. albicans</italic> and <italic>T. rubrum</italic>, respectively, in comparison to non-treated fungal cells. Overall, untreated cells showed a well-defined surface with and integral cell wall (<xref ref-type="fig" rid="antibiotics-10-00592-f003">Figure 3</xref>a,b; <xref ref-type="fig" rid="antibiotics-10-00592-f004">Figure 4</xref>a,b) while treated cells (<xref ref-type="fig" rid="antibiotics-10-00592-f003">Figure 3</xref>c&#x02013;h; <xref ref-type="fig" rid="antibiotics-10-00592-f004">Figure 4</xref>c&#x02013;h) presented a structural disorganization, particularly at the cell wall (e.g., <xref ref-type="fig" rid="antibiotics-10-00592-f003">Figure 3</xref>c and <xref ref-type="fig" rid="antibiotics-10-00592-f004">Figure 4</xref>c), for <italic>C. albicans</italic> and <italic>T. rubrum</italic> respectively. These alterations can be due to an impairment in the deposition of cell wall constituents. In <italic>C. albicans</italic> cytoplasmic disintegration was also observed (e.g., <xref ref-type="fig" rid="antibiotics-10-00592-f003">Figure 3</xref>h). Particularly for <italic>T. rubrum</italic> an increased number of vacuoles was observed with the accumulation of electron dense material (<xref ref-type="fig" rid="antibiotics-10-00592-f004">Figure 4</xref>c&#x02013;h), reflecting a defensive mechanism of the fungus. As the number of vacuoles significantly increased with the essential oil treatment, it seems that autophagy is activated [<xref rid="B35-antibiotics-10-00592" ref-type="bibr">35</xref>]. Indeed, autophagic structures were observed (<xref ref-type="fig" rid="antibiotics-10-00592-f004">Figure 4</xref>h), thus suggesting that the oil activates this pathway as a protective mechanism of the fungi.</p></sec></sec><sec id="sec2dot3-antibiotics-10-00592"><title>2.3. Anti-Inflammatory Activity</title><p>Chronic inflammation contributes to the successful colonization of the host tissues by pathogenic fungi, thus compromising disease suppression. Indeed, an antifungal drug with inherent anti-inflammatory activity, would enable a rapid symptomatic relief while providing an effective treatment. Therefore, we also assessed the anti-inflammatory potential of the essential oil using an in vitro model of lipopolysaccharide (LPS)-stimulated macrophages. The effect on NO production, a canonical marker of inflammation, was analyzed by measuring the accumulation of nitrites in the culture medium. Moreover, the effect of the oil on macrophages&#x02019; viability was also tested (<xref ref-type="fig" rid="antibiotics-10-00592-f005">Figure 5</xref>). Expectably, our results show that macrophages without LPS stimuli produced residual levels of nitrites (&#x0003c;1 &#x000b5;M) and this value increased to 35.25 &#x000b1; 3.91 &#x000b5;M in the presence of LPS (<xref ref-type="fig" rid="antibiotics-10-00592-f005">Figure 5</xref>a). Interestingly, nitrite production was significantly reduced in the presence of the essential oil, attaining a decrease of more than 51% with 576 &#x000b5;g/mL of the oil (17.15 &#x000b1; 3.35 &#x000b5;M) and a decrease of 33% with half the concentration (23.53 &#x000b1; 3.93 &#x000b5;M; <xref ref-type="fig" rid="antibiotics-10-00592-f005">Figure 5</xref>a). Importantly, all the tested concentrations of the essential oil did not affect macrophages&#x02019; viability (<xref ref-type="fig" rid="antibiotics-10-00592-f005">Figure 5</xref>b), thus confirming a safety profile of the oil at concentrations exhibiting pharmacological activity.</p></sec></sec><sec sec-type="discussion" id="sec3-antibiotics-10-00592"><title>3. Discussion</title><p><italic>Bupleurum rubrum</italic> subp. <italic>paniculatum</italic> essential oils from Portugal showed high amounts of monoterpene hydrocarbons with &#x003b1;-pinene, &#x003b2;-pinene and limonene standing out as the main compounds. Similar compounds were also reported for essential oils obtained from plants collected in Montes Toledo, Spain, although in these plants myrcene was also found in high amounts (26.2%) [<xref rid="B36-antibiotics-10-00592" ref-type="bibr">36</xref>]. These differences might be due to different growing locations with diverse abiotic factors that may influence the biosynthesis of essential oils. In a previous work, we developed a protocol for the in vitro propagation of <italic>Bupleurum</italic> species and observed the presence of the major compounds inside secretory ducts of the in vitro propagated plantlets of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> [<xref rid="B37-antibiotics-10-00592" ref-type="bibr">37</xref>]. Since secondary metabolites signature in spontaneous plants was also found in the in vitro propagated plants, this technique could enable a large-scale production of this species, thus reducing the influence of abiotic factors and enabling the production of uniform essential oils. Furthermore, this approach could allow a year-round plant supply.</p><p>To the best knowledge of the authors, no reports on the bioactive potential of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> have been conducted. Nevertheless, the antimicrobial activity of other <italic>Bupleurum</italic> species has already been reported. For example, the essential oil isolated from <italic>B. marginatum</italic>, rich in tridecane, undecane, pentadecane, &#x003b2;-caryophyllene and &#x003b2;-caryophyllene oxide, showed a MIC of 4 mg/mL towards two strains of <italic>C. albicans</italic> and inhibited several bacterial strains, including methicillin-resistant <italic>S. aureus</italic> (MIC = 0.063&#x02013;4 mg/mL) [<xref rid="B22-antibiotics-10-00592" ref-type="bibr">22</xref>]. The antifungal activity of <italic>B. gibraltaricum</italic>, characterized by sabinene, &#x003b1;-pinene and 2,3,4-trimethylbenzaldehyde, was demonstrated for <italic>Plasmopara halstedii</italic> through fungal sporulation inhibition at 5 mL/L [<xref rid="B30-antibiotics-10-00592" ref-type="bibr">30</xref>]. The essential oil from <italic>B. longiradiatum</italic>, having thymol, butylidene phthalide, 5-indolol, heptanal, 4-hydroxy-2-methylacetophenone, 4,5-diethyl-octane, borneol and hexanoic acid as main compounds, was able to inhibit the growth of several bacteria with MIC ranging from 250&#x02013;500 &#x003bc;g/mL [<xref rid="B27-antibiotics-10-00592" ref-type="bibr">27</xref>]. The essential oil herein presented showed a broad antifungal activity, very effective against <italic>Cryptococcus neoformans</italic> and <italic>Trichophyton rubrum</italic> (MIC = 72 &#x000b5;g/mL). The antifungal effect of the essential oil might be attributed to the presence of several compounds with strong antifungal activity, namely &#x003b1;-pinene, limonene, &#x003b2;-pinene and myrcene [<xref rid="B38-antibiotics-10-00592" ref-type="bibr">38</xref>,<xref rid="B39-antibiotics-10-00592" ref-type="bibr">39</xref>,<xref rid="B40-antibiotics-10-00592" ref-type="bibr">40</xref>,<xref rid="B41-antibiotics-10-00592" ref-type="bibr">41</xref>,<xref rid="B42-antibiotics-10-00592" ref-type="bibr">42</xref>,<xref rid="B43-antibiotics-10-00592" ref-type="bibr">43</xref>,<xref rid="B44-antibiotics-10-00592" ref-type="bibr">44</xref>,<xref rid="B45-antibiotics-10-00592" ref-type="bibr">45</xref>,<xref rid="B46-antibiotics-10-00592" ref-type="bibr">46</xref>]. Regarding the anti-virulent effects of <italic>Bupleurum</italic> spp., no studies have been conducted until now. Nevertheless, the major compounds of the essential oil were able to decrease the yeast-to-hypha transition in <italic>C. albicans</italic>. Indeed, &#x003b2;-pinene [<xref rid="B47-antibiotics-10-00592" ref-type="bibr">47</xref>,<xref rid="B48-antibiotics-10-00592" ref-type="bibr">48</xref>] and limonene [<xref rid="B48-antibiotics-10-00592" ref-type="bibr">48</xref>] were described as germ tube inhibitors. Similarly, the capacity of the oil to disrupt preformed <italic>C. albicans</italic> biofilms might also be attributed to the presence of limonene and &#x003b2;-pinene as both compounds have been described as effective in disrupting mature biofilms. Nevertheless, the influence of minor compounds cannot be discarded. Indeed, myrcene and <italic>p</italic>-cymene were also able to inhibit the formation of <italic>C. albicans</italic> biofilms [<xref rid="B48-antibiotics-10-00592" ref-type="bibr">48</xref>].</p><p>Regarding ultrastructural characterizations, studies on dermatophytes are scarce, thus highlighting the relevance of our results. In <italic>Candida</italic> species, essential oils tend to act on ergosterol synthesis, modify fungal cell morphology, modulate membrane permeability and produce reactive oxygen species [<xref rid="B49-antibiotics-10-00592" ref-type="bibr">49</xref>]. In accordance, our observations showed alterations in the cell wall structure as well as cytoplasmic disorganization, thus contributing to an overall modification of fungal cell morphology. Similar effects were reported for conventional antifungal drugs, namely caspofungin alone or in conjugation with pyroquilon in <italic>Alternaria infectoria</italic> [<xref rid="B50-antibiotics-10-00592" ref-type="bibr">50</xref>], suggesting a similar mechanism of action for <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> essential oils. Regarding <italic>T. rubrum</italic>, our results clearly show that the essential oil induces an increase in the number of vacuoles, thus suggesting an activation of autophagic pathways. Similar results were shown for <italic>Microsporum gypseum</italic> treated with resorcinol derivatives [<xref rid="B35-antibiotics-10-00592" ref-type="bibr">35</xref>].</p><p>Furthermore, the present study reports for the first time the anti-inflammatory potential of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic>. Nevertheless, other studies have pointed out promising effects for other <italic>Bupleurum</italic> species. For example, the essential oil from <italic>B. fruticosum</italic>, rich in &#x003b1;- and &#x003b2;-pinene, thymol and carvacrol, was able to decrease the edema in a carrageenan-induced edema model [<xref rid="B23-antibiotics-10-00592" ref-type="bibr">23</xref>] and that of <italic>B. frutiscens</italic>, characterized by &#x003b1;-pinene and &#x003b2;-caryophyllene, also showed effects in paw edema induced by carrageenan and prostaglandin (PG) E1 [<xref rid="B24-antibiotics-10-00592" ref-type="bibr">24</xref>]. Moreover, <italic>B. gibraltaricum</italic> essential oil with high amounts of &#x00394;-3-carene and &#x003b1;-pinene, showed anti-inflammatory effects in both carrageenan-induced paw edema and granuloma-induced inflammation [<xref rid="B51-antibiotics-10-00592" ref-type="bibr">51</xref>,<xref rid="B52-antibiotics-10-00592" ref-type="bibr">52</xref>]. Additionally, the production of PGE2 and the activity of lipoxygenase was decreased in the presence of <italic>B. marginatum</italic> essential oil [<xref rid="B22-antibiotics-10-00592" ref-type="bibr">22</xref>]. Overall, these results corroborate the anti-inflammatory effects observed in the present study as all species present similar major compounds to those found in <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic>, namely pinene isomers. Accordingly, several reports have shown the anti-inflammatory effect of isolated major compounds including &#x003b1;- and &#x003b2;-pinene as well as limonene [<xref rid="B53-antibiotics-10-00592" ref-type="bibr">53</xref>,<xref rid="B54-antibiotics-10-00592" ref-type="bibr">54</xref>,<xref rid="B55-antibiotics-10-00592" ref-type="bibr">55</xref>]. In addition, minor compounds, such as 1,8-cineole [<xref rid="B56-antibiotics-10-00592" ref-type="bibr">56</xref>], camphor [<xref rid="B56-antibiotics-10-00592" ref-type="bibr">56</xref>,<xref rid="B57-antibiotics-10-00592" ref-type="bibr">57</xref>] and &#x003b3;-terpinene [<xref rid="B58-antibiotics-10-00592" ref-type="bibr">58</xref>] have also been assessed in a plethora of assays, thus suggesting that these compounds may contribute to <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> anti-inflammatory potential.</p></sec><sec sec-type="conclusions" id="sec4-antibiotics-10-00592"><title>4. Conclusions</title><p>Overall, the present study provides evidence, for the first time, of the antifungal and anti-inflammatory potential of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> essential oil from Portugal. The oil showed high amounts of monoterpene hydrocarbons (94.4&#x02013;96.6%), namely &#x003b1;-pinene (29.0&#x02013;36.0%), &#x003b2;-pinene (26.1&#x02013;30.7%) and limonene (10.5&#x02013;13.5%) and demonstrated a broad fungicidal effect, particularly against <italic>Cryptococcus neoformans</italic> and <italic>Trichophyton rubrum</italic>. Moreover, a significant germ tube inhibition as well as a disruption of mature biofilms for <italic>C. albicans</italic> was pointed out and for both <italic>C. albicans</italic> and <italic>T. rubrum</italic> significant ultrastructural alterations were observed. Finally, <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> essential oil also evidenced anti-inflammatory activity, without affecting macrophages&#x000b4; viability, further endorsing its exploitation as a natural source of bioactive compounds for the development of drugs with concomitant antifungal and anti-inflammatory effects. Nevertheless, further in vivo studies are needed to validate the efficacy of the essential oil. Moreover, the clinical relevance of our results depends on the availability of the essential oil on target organs. Therefore, pharmacokinetic studies are essential to link in vitro effects to in vivo efficacy.</p></sec><sec id="sec5-antibiotics-10-00592"><title>5. Materials and Methods</title><sec id="sec5dot1-antibiotics-10-00592"><title>5.1. Plant Material</title><p>Aerial parts of two samples of <italic>B. rigidum</italic> subsp. <italic>paniculatum</italic> (~1 kg) were collected from field-growing plants in the flowering stage in central Portugal [A&#x02014;Coimbra region (40&#x000b0;14&#x02032;52.4&#x02033; N 8&#x000b0;25&#x02032;14.1&#x02033; W), B&#x02014;Fatima region (39&#x000b0;37&#x02032;28.6&#x02033; N 8&#x000b0;41&#x02032;19.7&#x02033; W)]. Voucher specimens were deposited at the herbarium of the Department of Life Sciences of the University of Coimbra (COI).</p></sec><sec id="sec5dot2-antibiotics-10-00592"><title>5.2. Essential Oil Isolation and Chemical Analysis</title><p>The essential oils were obtained by hydrodistillation (3 h) using a Clevenger-type apparatus as described in the European Pharmacopoeia [<xref rid="B59-antibiotics-10-00592" ref-type="bibr">59</xref>]. Their chemical characterization was carried out using both gas chromatography (GC) and gas chromatography coupled to mass spectrometry (GC-MS).</p><p>A Hewlett-Packard 6890 (Agilent Technologies, Palo Alto, CA, USA) chromatograph with a single injector, two flame ionization detectors and a HP GC ChemStation Rev. A.05.04 data handling system was used for GC analysis. Two columns: polydimethylsiloxane (SPB-1) and polyethylene glycol (SupelcoWax-10) with 30 m &#x000d7; 0.20 mm and a film thickness 0.20 &#x000b5;m were used and GC parameters were as follows: oven temperature: 70&#x02013;220 &#x000b0;C (3 &#x000b0;C/min), 220 &#x000b0;C (15 min); injector temperature: 250 &#x000b0;C; carrier gas: helium, with a linear velocity of 30 cm/s; splitting ratio 1:40; detectors temperature: 250 &#x000b0;C. A Hewlett-Packard 6890 gas chromatograph (SPB-1 column), interfaced with an Hewlett-Packard mass selective detector 5973 (Agilent Technologies, Centerville Road Wilmington, DE, USA) with a HP Enhanced ChemStation software, version A.03.00 (Agilent Technologies, Palo Alto, CA, USA) was used for GC&#x02013;MS analysis. MS parameters: source temperature: 230 &#x000b0;C; MS quadruple temperature: 150 &#x000b0;C; ionization energy: 70 eV; ionization current: 60 &#x000b5;A; scan range: 35&#x02013;350 units; scans per second: 4.51; interface temperature: 250 &#x000b0;C.</p><p>Retention indices and mass spectra were used to identify the compounds with the first being compared to samples from the Laboratory of Pharmacognosy database of the Faculty of Pharmacy, University of Coimbra and the later with that of reference spectra from a home-made library or from literature data. GC peak area was used to calculate relative amounts of the identified compounds.</p></sec><sec id="sec5dot3-antibiotics-10-00592"><title>5.3. Antifungal Activity</title><sec id="sec5dot3dot1-antibiotics-10-00592"><title>5.3.1. Fungal Strains</title><p>Collection and clinical strains were used to assess the antifungal effect of the essential oil, including yeasts: <italic>Candida albicans</italic> ATCC 10231, <italic>C. guillermondii</italic> MAT23, <italic>C. krusei</italic> H9, <italic>C. parapsilosis</italic> ATCC 90018, <italic>C. tropicalis</italic> ATCC 13803, and <italic>Cryptococcus neoformans</italic> CECT 1078; dermatophytes: <italic>Epidermophyton floccosum</italic> FF9, <italic>Microsporum canis</italic> FF1, <italic>M. gypseum</italic> CECT 2908, <italic>Trichophyton mentagrophytes</italic> FF7, <italic>T. mentagrophytes</italic> var. <italic>interdigitale</italic> CECT 2958, <italic>T. rubrum</italic> CECT 2794, and <italic>T. verrucosum</italic> CECT 2992 and <italic>Aspergillus</italic> strains including <italic>A. flavus</italic> F44, <italic>A. fumigatus</italic> ATCC 46645 and <italic>A. niger</italic> ATCC 16404.</p><p>The fungal isolates were identified by standard microbiological methods and stored at &#x02212;80 &#x000b0;C on Sabouraud broth with 20% glycerol, being inoculated on Sabouraud dextrose agar (SDA) to ensure optimal growth and purity, prior to each assay.</p></sec><sec id="sec5dot3dot2-antibiotics-10-00592"><title>5.3.2. Fungal Growth</title><p>To assess the effect of the essential oil on fungal growth, two parameters were assessed: the minimal inhibitory concentration (MIC) and the minimal lethal concentration (MLC). A broth macrodilution method was used according to the Clinical and Laboratory Standards Institute (CLSI) reference protocols M27-A3 and M38-A2, for yeasts and filamentous fungi, respectively. Serial dilutions of the oil (up to 0.036 &#x000b5;g/mL) were tested as well as a negative control (medium without fungi) and a positive control (inoculated medium with DMSO 1%).</p></sec><sec id="sec5dot3dot3-antibiotics-10-00592"><title>5.3.3. Fungal Ultrastructure</title><p><italic>C. albicans</italic> and <italic>T. rubrum</italic> were selected to perform the transmission electron microscopy studies. Cultures untreated (DMSO 1%) or treated with the essential oil (MIC) were used. Fungi cultures were collected and centrifuged at 3000 rpm for 5 min. Pellet cells were fixed using 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 2 h and post-fixed in 1% osmium tetroxide during 1 h. Following rinsing, samples were embedded in 2% molten agar, dehydrated in ethanol (30&#x02013;100%), and impregnated and included in epoxy resin (Sigma Aldrich, St. Louis, MO, USA). Ultrathin sections (70 nm) were obtained and stained with uranyl acetate 2%, for 5 min followed by lead citrate 0.2% for 5 min. Observations were carried out on a FEI Tecnai G2 Spirit Bio Twin at 100 kV.</p></sec><sec id="sec5dot3dot4-antibiotics-10-00592"><title>5.3.4. <italic>Candida albicans</italic> Germ Tube Formation</title><p>To assess the effect of the oil on the yeast&#x02013;hyphae transition, cell suspensions of <italic>C. albicans</italic> ATCC 10231, from overnight cultures on SDA, were prepared in NYP medium [N-acetylglucosamine (10&#x02013;3 mol/L), Yeast Nitrogen Base (3.35 g/L), proline (10&#x02013;3 mol/L), NaCl (4.5 g/L), and pH 6.7 &#x000b1; 0.1] [<xref rid="B60-antibiotics-10-00592" ref-type="bibr">60</xref>]. The suspensions were adjusted to a density of 1.0 &#x000b1; 0.2 &#x000d7; 10<sup>6</sup> CFU/mL and then distributed into glass test tubes (990 &#x003bc;L). Then, subinhibitory concentrations of the essential oil or fluconazole (10 &#x000b5;L) were added and incubated without agitation for 3 h, at 37 &#x000b0;C. The number of germ tubes (germinating protuberance at least as long as the diameter of the blastopore) were recorded using a light microscope (40&#x000d7;) and DMSO 1% (<italic>v</italic>/<italic>v</italic>) was used as a positive control.</p></sec><sec id="sec5dot3dot5-antibiotics-10-00592"><title>5.3.5. <italic>Candida albicans</italic> Biofilm Disruption</title><p>Serial dilutions of the essential oil (1125&#x02013;72 &#x000b5;g/mL) and fluconazole (200&#x02013;1 &#x000b5;g/mL) were used to assess their effect on mature biofilms, as reported elsewhere [<xref rid="B61-antibiotics-10-00592" ref-type="bibr">61</xref>]. <italic>C. albicans</italic> density was adjusted to 1 &#x000d7; 10<sup>6</sup> CFU/mL and 100 &#x003bc;L of this suspension added to 96-well microtiter plates and incubated for 24 h at 37 &#x000b0;C for biofilm adhesion and formation, followed by 24 h at 37 &#x000b0;C in the presence or absence of the essential oils.</p><p>Biofilm viability was determined using the XTT/menadione metabolic assay. Briefly, menadione (10 mM in acetone) was added to a XTT solution (1 mg/mL in PBS) to a final concentration of 4 &#x000b5;M. A volume of 100 &#x000b5;L of this solution was added to each well and incubated for 2 h at 37 &#x000b0;C in the dark. The absorbance was measured at 490 nm and cell viability expressed as [(AbsT/AbsC) &#x000d7; 100], where AbsT represents the absorbance of the treated cells and AbsC the absorbance of control cells (without essential oil or fluconazole).</p><p>Biofilm biomass was assessed using the crystal violet assay. Following the treatment period, performed as referred above, the culture medium was removed and cells were fixed with methanol 99% for 15 min. The supernatant was discarded, and the wells air dried. Then, 100 &#x000b5;L of crystal violet (CV) solution (0.02%) was added to each well and left to stain the biofilm for 15 min. After CV removal, the wells were washed twice with sterile water to remove excessive reagent. Then, 150 &#x000b5;L of acetic acid 33% were added to release the stain from the cells and the supernatant was transferred to a 96-well microtiter plate. The absorbance was then read at 620 nm using a microtiter plate reader. Biomass decrease was determined as [(AbsT/AbsC) &#x000d7; 100], where AbsT represents the absorbance of each treated well and AbsC the absorbance in the control wells. Negative and positive controls comprising biofilm-free and oil-free wells, respectively, were also included.</p></sec></sec><sec id="sec5dot4-antibiotics-10-00592"><title>5.4. Anti-Inflammatory Activity</title><sec id="sec5dot4dot1-antibiotics-10-00592"><title>5.4.1. Cell Culture</title><p>The mouse macrophage cell line, Raw 264.7 (ATCC number: TIB-71) was kindly supplied by Dr. Otilia Vieira (CEDOC, Faculdade de Ci&#x000ea;ncias M&#x000e9;dicas, Universidade Nova de Lisboa). The cells were cultured on endotoxin-free Dulbecco&#x02019;s Modified Eagle Medium (DMEM) supplemented with 10% (<italic>v</italic>/<italic>v</italic>) non-inactivated fetal bovine serum, 3.02 g/L sodium bicarbonate, 100 &#x000b5;g/mL streptomycin and 100 U/mL penicillin at 37 &#x000b0;C in a humidified atmosphere with 5% CO<sub>2</sub>. Morphological appearance of macrophages was microscopically monitored during the assays.</p></sec><sec id="sec5dot4dot2-antibiotics-10-00592"><title>5.4.2. Assessment of Nitric Oxide (NO) Production</title><p>To evaluate the anti-inflammatory potential of the oils, the in vitro model of lipopolysaccharide (LPS)-stimulated macrophages was used. The cells (0.6 &#x000d7; 10<sup>6</sup> cells/well) were cultured in a 48-well microplate and left to stabilize for 12 h. The cells were then incubated for 24 h in the culture medium alone (control) or with different concentrations of the essential oils (144&#x02013;576 &#x000b5;g/mL).The production of nitric oxide (NO) was measured by the accumulation of nitrites in the culture medium, using the colorimetric Griess reaction. Briefly, 170 &#x000b5;L of culture supernatants were added to an equal volume of Griess reagent [0.1% (<italic>w</italic>/<italic>v</italic>) N-(1-naphthyl)-ethylenediamine dihydrochloride and 1% (<italic>w</italic>/<italic>v</italic>) sulphanilamide containing 5% (<italic>w</italic>/<italic>v</italic>) H<sub>3</sub>PO<sub>4</sub>] and maintained for 30 min, in the dark. Absorbance was measured using an ELISA automatic microplate reader (SLT, Austria) at 550 nm and the nitrite concentration determined from a regression analysis prepared with serial dilutions of sodium nitrite.</p></sec><sec id="sec5dot4dot3-antibiotics-10-00592"><title>5.4.3. Assessment of Cell Viability</title><p>Cell respiration, an indicator of cell viability, was performed using a colorimetric assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). The cells were cultured and treated as referred above. After cells treatments, 43 &#x000b5;L of MTT solution (5 mg/mL in phosphate buffered saline) were added to each well and the microplates were further incubated at 37 &#x000b0;C for 15 min, in a humidified atmosphere with 5% CO<sub>2</sub>. Supernatants were centrifuged (1000&#x000d7; <italic>g</italic> during 5 min) to recover viable cells. To dissolve formazan crystals formed in adherent cells in the microplates, 300 &#x000b5;L of acidified isopropanol (0.04 M HCl in isopropanol) were added to each cell and recovered to the respective tube containing the pellet formed after centrifugation. Quantification of formazan was performed using an ELISA automatic microplate reader (SLT, Salzburg, Austria) at 570 nm.</p></sec></sec><sec id="sec5dot5-antibiotics-10-00592"><title>5.5. Statistical Analysis</title><p>The results presented as mean &#x000b1; SD are from experiments performed at least in triplicate. The statistical test one-way ANOVA followed by Dunnett&#x02019;s Multiple Comparison Test were performed using GraphPad Prism, version 6 (GraphPad Software, San Diego, CA, USA).</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>Electron microscopy analysis were carried out at the Microscopy and Bioimaging Lab of the Faculty of Medicine of the University of Coimbra, supported by the Portuguese Platform of Bioimaging, PPBI&#x02013;POCI-01-0145-FEDER-02212. </p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, M.Z. and L.S.; methodology, M.Z., P.M.P.C., J.M.A.-S., M.J.G., C.C.; validation, P.M.P.C., J.M.A.-S.; formal analysis, M.Z., J.M.A.-S.; investigation, M.Z., M.J.G., P.M.P.C.; resources, C.C., T.C., L.S.; writing&#x02014;original draft preparation, M.Z.; writing&#x02014;P.M.P.C., J.M.A.-S., C.C., M.J.G., T.C., L.S.; visualization, M.Z., J.M.A.-S.; supervision, L.S.; funding acquisition, T.C., L.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work was financed by the European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01-0145-FEDER-000012 (HealthyAging2020).</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data is contained within the article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-antibiotics-10-00592"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bongomin</surname><given-names>F.</given-names></name><name><surname>Gago</surname><given-names>S.</given-names></name><name><surname>Oladele</surname><given-names>R.</given-names></name><name><surname>Denning</surname><given-names>D.</given-names></name></person-group><article-title>Global and multi-national prevalence of fungal diseases&#x02014;Estimate precision</article-title><source>J. Fungi</source><year>2017</year><volume>3</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.3390/jof3040057</pub-id></element-citation></ref><ref id="B2-antibiotics-10-00592"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>C.</given-names></name><name><surname>Lopez-Ribot</surname><given-names>J.L.</given-names></name></person-group><article-title>Candidiasis drug discovery and development: New approaches targeting virulence for discovering and identifying new drugs</article-title><source>Expert Opin. Drug Discov.</source><year>2013</year><volume>8</volume><fpage>1117</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1517/17460441.2013.807245</pub-id><?supplied-pmid 23738751?><pub-id pub-id-type="pmid">23738751</pub-id></element-citation></ref><ref id="B3-antibiotics-10-00592"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makanjuola</surname><given-names>O.</given-names></name><name><surname>Bongomin</surname><given-names>F.</given-names></name><name><surname>Fayemiwo</surname><given-names>S.</given-names></name></person-group><article-title>An Update on the roles of non-albicans <italic>Candida</italic> species in vulvovaginitis</article-title><source>J. Fungi</source><year>2018</year><volume>4</volume><elocation-id>121</elocation-id><pub-id pub-id-type="doi">10.3390/jof4040121</pub-id><?supplied-pmid 30384449?><pub-id pub-id-type="pmid">30384449</pub-id></element-citation></ref><ref id="B4-antibiotics-10-00592"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dadar</surname><given-names>M.</given-names></name><name><surname>Tiwari</surname><given-names>R.</given-names></name><name><surname>Karthik</surname><given-names>K.</given-names></name><name><surname>Chakraborty</surname><given-names>S.</given-names></name><name><surname>Shahali</surname><given-names>Y.</given-names></name><name><surname>Dhama</surname><given-names>K.</given-names></name></person-group><article-title><italic>Candida albicans&#x02014;</italic>Biology, molecular characterization, pathogenicity, and advances in diagnosis and control&#x02014;An update</article-title><source>Microb. Pathog.</source><year>2018</year><volume>117</volume><fpage>128</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.02.028</pub-id><pub-id pub-id-type="pmid">29454824</pub-id></element-citation></ref><ref id="B5-antibiotics-10-00592"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romo</surname><given-names>J.A.</given-names></name><name><surname>Pierce</surname><given-names>C.G.</given-names></name><name><surname>Chaturvedi</surname><given-names>A.K.</given-names></name><name><surname>Lazzell</surname><given-names>A.L.</given-names></name><name><surname>McHardy</surname><given-names>S.F.</given-names></name><name><surname>Saville</surname><given-names>S.P.</given-names></name><name><surname>Lopez-Ribot</surname><given-names>J.L.</given-names></name></person-group><article-title>Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of <italic>Candida albicans</italic> filamentation</article-title><source>mBio</source><year>2017</year><volume>8</volume><pub-id pub-id-type="doi">10.1128/mBio.01991-17</pub-id></element-citation></ref><ref id="B6-antibiotics-10-00592"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>S.</given-names></name><name><surname>Rodrigues</surname><given-names>C.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>D.</given-names></name><name><surname>Rodrigues</surname><given-names>M.</given-names></name><name><surname>Henriques</surname><given-names>M.</given-names></name></person-group><article-title><italic>Candida</italic> species biofilms&#x02019; antifungal resistance</article-title><source>J. Fungi</source><year>2017</year><volume>3</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.3390/jof3010008</pub-id></element-citation></ref><ref id="B7-antibiotics-10-00592"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Kim</surname><given-names>Y.-G.</given-names></name><name><surname>Gupta</surname><given-names>V.K.</given-names></name><name><surname>Manoharan</surname><given-names>R.K.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group><article-title>Suppression of fluconazole resistant <italic>Candida albicans</italic> biofilm formation and filamentation by methylindole derivatives</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><pub-id pub-id-type="doi">10.3389/fmicb.2018.02641</pub-id></element-citation></ref><ref id="B8-antibiotics-10-00592"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugui</surname><given-names>J.A.</given-names></name><name><surname>Kwon-Chung</surname><given-names>K.J.</given-names></name><name><surname>Juvvadi</surname><given-names>P.R.</given-names></name><name><surname>Latge</surname><given-names>J.-P.</given-names></name><name><surname>Steinbach</surname><given-names>W.J.</given-names></name></person-group><article-title><italic>Aspergillus fumigatus</italic> and related species</article-title><source>Cold Spring Harb. Perspect. Med.</source><year>2015</year><volume>5</volume><fpage>a019786</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a019786</pub-id></element-citation></ref><ref id="B9-antibiotics-10-00592"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuentefria</surname><given-names>A.M.</given-names></name><name><surname>Pippi</surname><given-names>B.</given-names></name><name><surname>Dalla Lana</surname><given-names>D.F.</given-names></name><name><surname>Donato</surname><given-names>K.K.</given-names></name><name><surname>de Andrade</surname><given-names>S.F.</given-names></name></person-group><article-title>Antifungals discovery: An insight into new strategies to combat antifungal resistance</article-title><source>Lett. Appl. Microbiol.</source><year>2018</year><volume>66</volume><fpage>2</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1111/lam.12820</pub-id><?supplied-pmid 29112282?><pub-id pub-id-type="pmid">29112282</pub-id></element-citation></ref><ref id="B10-antibiotics-10-00592"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Rossi</surname><given-names>N.M.</given-names></name><name><surname>Bitencourt</surname><given-names>T.A.</given-names></name><name><surname>Peres</surname><given-names>N.T.A.</given-names></name><name><surname>Lang</surname><given-names>E.A.S.</given-names></name><name><surname>Gomes</surname><given-names>E.V.</given-names></name><name><surname>Quaresemin</surname><given-names>N.R.</given-names></name><name><surname>Martins</surname><given-names>M.P.</given-names></name><name><surname>Lopes</surname><given-names>L.</given-names></name><name><surname>Rossi</surname><given-names>A.</given-names></name></person-group><article-title>Dermatophyte resistance to antifungal drugs: Mechanisms and prospectus</article-title><source>Front. Microbiol.</source><year>2018</year><volume>9</volume><pub-id pub-id-type="doi">10.3389/fmicb.2018.01108</pub-id></element-citation></ref><ref id="B11-antibiotics-10-00592"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>A.L.</given-names></name><name><surname>de Almeida J&#x000fa;nior</surname><given-names>J.N.</given-names></name><name><surname>Guinea</surname><given-names>J.</given-names></name></person-group><article-title>Emerging multidrug-resistant <italic>Candida</italic> species</article-title><source>Curr. Opin. Infect. Dis.</source><year>2017</year><volume>30</volume><fpage>528</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1097/QCO.0000000000000411</pub-id><?supplied-pmid 29095200?><pub-id pub-id-type="pmid">29095200</pub-id></element-citation></ref><ref id="B12-antibiotics-10-00592"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taghavi</surname><given-names>M.</given-names></name><name><surname>Khosravi</surname><given-names>A.</given-names></name><name><surname>Mortaz</surname><given-names>E.</given-names></name><name><surname>Nikaein</surname><given-names>D.</given-names></name><name><surname>Athari</surname><given-names>S.S.</given-names></name></person-group><article-title>Role of pathogen-associated molecular patterns (PAMPS) in immune responses to fungal infections</article-title><source>Eur. J. Pharm.</source><year>2017</year><volume>808</volume><fpage>8</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2016.11.013</pub-id></element-citation></ref><ref id="B13-antibiotics-10-00592"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>H.</given-names></name><name><surname>Cui</surname><given-names>H.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Zuo</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name></person-group><article-title>Inflammatory responses and inflammation-associated diseases in organs</article-title><source>Oncotarget</source><year>2018</year><volume>9</volume><fpage>7204</fpage><lpage>7218</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.23208</pub-id><?supplied-pmid 29467962?><pub-id pub-id-type="pmid">29467962</pub-id></element-citation></ref><ref id="B14-antibiotics-10-00592"><label>14.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vega</surname><given-names>R.J.S.</given-names></name><name><surname>Xolalpa</surname><given-names>N.C.</given-names></name><name><surname>Castro</surname><given-names>A.J.A.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>C.P.</given-names></name><name><surname>Ramos</surname><given-names>J.P.</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>S.P.</given-names></name></person-group><article-title>Terpenes from natural products with potential anti-inflammatory activity</article-title><source>Terpenes and Terpenoids</source><publisher-name>IntechOpen</publisher-name><publisher-loc>London, UK</publisher-loc><year>2018</year><fpage>59</fpage><lpage>85</lpage></element-citation></ref><ref id="B15-antibiotics-10-00592"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>S.-C.</given-names></name></person-group><article-title>The non-canonical NF-&#x003ba;B pathway in immunity and inflammation</article-title><source>Nat. Rev. Immunol.</source><year>2017</year><volume>17</volume><fpage>545</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1038/nri.2017.52</pub-id><pub-id pub-id-type="pmid">28580957</pub-id></element-citation></ref><ref id="B16-antibiotics-10-00592"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumamoto</surname><given-names>C.A.</given-names></name></person-group><article-title>Inflammation and gastrointestinal <italic>Candida</italic> colonization</article-title><source>Curr. Opin. Microbiol.</source><year>2011</year><volume>14</volume><fpage>386</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2011.07.015</pub-id><?supplied-pmid 21802979?><pub-id pub-id-type="pmid">21802979</pub-id></element-citation></ref><ref id="B17-antibiotics-10-00592"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindu</surname><given-names>S.</given-names></name><name><surname>Mazumder</surname><given-names>S.</given-names></name><name><surname>Bandyopadhyay</surname><given-names>U.</given-names></name></person-group><article-title>Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective</article-title><source>Biochem. Pharm.</source><year>2020</year><volume>180</volume><fpage>114147</fpage><pub-id pub-id-type="doi">10.1016/j.bcp.2020.114147</pub-id><?supplied-pmid 32653589?><pub-id pub-id-type="pmid">32653589</pub-id></element-citation></ref><ref id="B18-antibiotics-10-00592"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves-Silva</surname><given-names>J.M.</given-names></name><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M.J.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Cruz</surname><given-names>M.T.</given-names></name><name><surname>Cardoso</surname><given-names>S.M.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title>New claims for wild carrot (<italic>Daucus carota</italic> subsp. <italic>carota</italic>) essential oil</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2016</year><volume>2016</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1155/2016/9045196</pub-id></element-citation></ref><ref id="B19-antibiotics-10-00592"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>J.</given-names></name><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Resende</surname><given-names>R.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M.J.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Pereira</surname><given-names>C.F.</given-names></name><name><surname>Cruz</surname><given-names>M.T.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title><italic>Daucus carota</italic> subsp. <italic>gummifer</italic> essential oil as a natural source of antifungal and anti-inflammatory drugs</article-title><source>Ind. Crop. Prod.</source><year>2015</year><volume>65</volume><fpage>361</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1016/j.indcrop.2014.11.014</pub-id></element-citation></ref><ref id="B20-antibiotics-10-00592"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>R.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name></person-group><article-title>Traditional use, pharmacology, toxicology, and quality control of species in genus <italic>Bupleurum</italic> L.</article-title><source>Chin. Herb. Med.</source><year>2013</year><volume>5</volume><fpage>245</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/S1674-6384(13)60036-2</pub-id><pub-id pub-id-type="pmid">32288759</pub-id></element-citation></ref><ref id="B21-antibiotics-10-00592"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prieto</surname><given-names>J.M.</given-names></name><name><surname>Ogunsina</surname><given-names>M.O.</given-names></name><name><surname>Novak</surname><given-names>A.</given-names></name><name><surname>Joshi</surname><given-names>A.</given-names></name><name><surname>Kokai</surname><given-names>J.</given-names></name><name><surname>Rocha</surname><given-names>I.D.C.</given-names></name><name><surname>de Santayana</surname><given-names>M.P.</given-names></name></person-group><article-title>Comparative study of the in vitro bioactivities of <italic>Bupleurum rigidum</italic> and <italic>B. fruticescens</italic></article-title><source>Nat. Prod. Commun.</source><year>2012</year><volume>7</volume><pub-id pub-id-type="doi">10.1177/1934578X1200700617</pub-id></element-citation></ref><ref id="B22-antibiotics-10-00592"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashour</surname><given-names>M.L.</given-names></name><name><surname>El-Readi</surname><given-names>M.</given-names></name><name><surname>Youns</surname><given-names>M.</given-names></name><name><surname>Mulyaningsih</surname><given-names>S.</given-names></name><name><surname>Sporer</surname><given-names>F.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Wink</surname><given-names>M.</given-names></name></person-group><article-title>Chemical composition and biological activity of the essential oil obtained from <italic>Bupleurum marginatum</italic> (Apiaceae)</article-title><source>J. Pharm. Pharm.</source><year>2009</year><volume>61</volume><fpage>1079</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1211/jpp/61.08.0012</pub-id></element-citation></ref><ref id="B23-antibiotics-10-00592"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorente</surname><given-names>I.</given-names></name><name><surname>Ocete</surname><given-names>M.A.</given-names></name><name><surname>Zarzuelo</surname><given-names>A.</given-names></name><name><surname>Cabo</surname><given-names>M.M.</given-names></name><name><surname>Jimenez</surname><given-names>J.</given-names></name></person-group><article-title>Bioactivity of the essential oil of <italic>Bupleurum fruticosum</italic></article-title><source>J. Nat. Prod.</source><year>1989</year><volume>52</volume><fpage>267</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1021/np50062a008</pub-id><pub-id pub-id-type="pmid">2746256</pub-id></element-citation></ref><ref id="B24-antibiotics-10-00592"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>S.</given-names></name><name><surname>Padilla</surname><given-names>E.</given-names></name><name><surname>Ocete</surname><given-names>M.</given-names></name><name><surname>Galvez</surname><given-names>J.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>J.</given-names></name><name><surname>Zarzuelo</surname><given-names>A.</given-names></name></person-group><article-title>Anti-inflammatory activity of the essential oil of <italic>Bupleurum Fruticescens</italic></article-title><source>Planta Med.</source><year>1993</year><volume>59</volume><fpage>533</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1055/s-2006-959755</pub-id><pub-id pub-id-type="pmid">8302953</pub-id></element-citation></ref><ref id="B25-antibiotics-10-00592"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guinea</surname><given-names>M.</given-names></name><name><surname>Parellada</surname><given-names>J.</given-names></name><name><surname>Lacaille-Dubois</surname><given-names>M.</given-names></name><name><surname>Wagner</surname><given-names>H.</given-names></name></person-group><article-title>Biologically active triterpene saponins from <italic>Bupleurum fruticosum</italic></article-title><source>Planta Med.</source><year>1994</year><volume>60</volume><fpage>163</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1055/s-2006-959442</pub-id><pub-id pub-id-type="pmid">8202567</pub-id></element-citation></ref><ref id="B26-antibiotics-10-00592"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>M.-H.</given-names></name><name><surname>Weng</surname><given-names>T.-C.</given-names></name><name><surname>Liu</surname><given-names>S.-Y.</given-names></name><name><surname>Chai</surname><given-names>C.-Y.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name></person-group><article-title>The hepatoprotective effect of <italic>Bupleurum kaoi</italic>, an endemic plant to Taiwan, against dimethylnitrosamine-induced hepatic fibrosis in rats</article-title><source>Biol. Pharm. Bull.</source><year>2005</year><volume>28</volume><fpage>442</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1248/bpb.28.442</pub-id><pub-id pub-id-type="pmid">15744066</pub-id></element-citation></ref><ref id="B27-antibiotics-10-00592"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wei</surname><given-names>S.-P.</given-names></name><name><surname>Wu</surname><given-names>W.-J.</given-names></name></person-group><article-title>Chemical composition, antibacterial and antioxidant activity of the essential oil of <italic>Bupleurum longiradiatum</italic></article-title><source>Nat. Prod. Commun.</source><year>2010</year><volume>5</volume><fpage>1139</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1177/1934578X1000500734</pub-id><?supplied-pmid 20734959?><pub-id pub-id-type="pmid">20734959</pub-id></element-citation></ref><ref id="B28-antibiotics-10-00592"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafaghat</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant, antimicrobial activities and fatty acid components of leaf and seed of <italic>Bupleurum lancifolium</italic> hornem</article-title><source>J. Med. Plants Res.</source><year>2011</year><volume>5</volume><fpage>3758</fpage><lpage>3762</lpage></element-citation></ref><ref id="B29-antibiotics-10-00592"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maxia</surname><given-names>A.</given-names></name><name><surname>Frau</surname><given-names>M.A.</given-names></name><name><surname>Marongiu</surname><given-names>B.</given-names></name><name><surname>Piras</surname><given-names>A.</given-names></name><name><surname>Porcedda</surname><given-names>S.</given-names></name><name><surname>Falconieri</surname><given-names>D.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M.J.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title>Biological assays and chemical composition of volatile oils of <italic>Bupleurum fruticosum</italic> L. (Apiaceae)</article-title><source>Rec. Nat. Prod.</source><year>2011</year><volume>5</volume><fpage>92</fpage><lpage>99</lpage></element-citation></ref><ref id="B30-antibiotics-10-00592"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Oca&#x000f1;a</surname><given-names>A.M.</given-names></name><name><surname>G&#x000f3;mez-Rodr&#x000ed;guez</surname><given-names>M.V.</given-names></name><name><surname>Velasco-Negueruela</surname><given-names>A.</given-names></name><name><surname>Camacho-Simarro</surname><given-names>A.M.</given-names></name><name><surname>Fern&#x000e1;ndez-L&#x000f3;pez</surname><given-names>C.</given-names></name><name><surname>Altarejos</surname><given-names>J.</given-names></name></person-group><article-title>In vivo antifungal activity of the essential oil of <italic>Bupleurum gibraltarium</italic> against <italic>Plasmopara halstedii</italic> in sunflower</article-title><source>J. Agric. Food Chem.</source><year>2004</year><volume>52</volume><fpage>6414</fpage><lpage>6417</lpage><pub-id pub-id-type="doi">10.1021/jf040219n</pub-id><pub-id pub-id-type="pmid">15479000</pub-id></element-citation></ref><ref id="B31-antibiotics-10-00592"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lartaud</surname><given-names>P.</given-names></name><name><surname>Pegeon</surname><given-names>A.</given-names></name><name><surname>Pelletier</surname><given-names>P.</given-names></name></person-group><source>Cosmetic Use of Essential Oil of Bupleurum fruticosum 2011</source><comment>WO/2012/080992</comment><publisher-name>L&#x02019;OREAL</publisher-name><publisher-loc>Clichy, France</publisher-loc><year>2012</year></element-citation></ref><ref id="B32-antibiotics-10-00592"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>S.S.</given-names></name><name><surname>Lanza</surname><given-names>A.M.D.</given-names></name><name><surname>Pajares</surname><given-names>M.B.</given-names></name><name><surname>Esteban</surname><given-names>C.B.</given-names></name><name><surname>Castillo</surname><given-names>L.V.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>M.J.A.</given-names></name><name><surname>Benito</surname><given-names>P.B.</given-names></name><name><surname>Matellano</surname><given-names>L.F.</given-names></name></person-group><article-title>Bioactive components of <italic>Bupleurum rigidum</italic> L. subsp. <italic>rigidum</italic></article-title><source>Studies in Natural Products Chemistry</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2002</year><fpage>659</fpage><lpage>696</lpage></element-citation></ref><ref id="B33-antibiotics-10-00592"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukaremera</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>K.K.</given-names></name><name><surname>Mora-Montes</surname><given-names>H.M.</given-names></name><name><surname>Gow</surname><given-names>N.A.R.</given-names></name></person-group><article-title><italic>Candida albicans</italic> yeast, pseudohyphal, and hyphal morphogenesis differentially affects immune recognition</article-title><source>Front. Immunol.</source><year>2017</year><volume>8</volume><fpage>629</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00629</pub-id><?supplied-pmid 28638380?><pub-id pub-id-type="pmid">28638380</pub-id></element-citation></ref><ref id="B34-antibiotics-10-00592"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>N.N.R.</given-names></name><name><surname>Alviano</surname><given-names>C.S.</given-names></name><name><surname>Blank</surname><given-names>A.F.</given-names></name><name><surname>Romanos</surname><given-names>M.T.V.</given-names></name><name><surname>Fonseca</surname><given-names>B.B.</given-names></name><name><surname>Rozental</surname><given-names>S.</given-names></name><name><surname>Rodrigues</surname><given-names>I.A.</given-names></name><name><surname>Alviano</surname><given-names>D.S.</given-names></name></person-group><article-title>Synergism effect of the essential oil from <italic>Ocimum basilicum</italic> var. Maria Bonita and its major components with fluconazole and its influence on ergosterol biosynthesis</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2016</year><volume>2016</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2016/5647182</pub-id><?supplied-pmid 27274752?><pub-id pub-id-type="pmid">27274752</pub-id></element-citation></ref><ref id="B35-antibiotics-10-00592"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romagnoli</surname><given-names>C.</given-names></name><name><surname>Baldisserotto</surname><given-names>A.</given-names></name><name><surname>Vicentini</surname><given-names>C.</given-names></name><name><surname>Mares</surname><given-names>D.</given-names></name><name><surname>Andreotti</surname><given-names>E.</given-names></name><name><surname>Vertuani</surname><given-names>S.</given-names></name><name><surname>Manfredini</surname><given-names>S.</given-names></name></person-group><article-title>Antidermatophytic action of resorcinol derivatives: Ultrastructural evidence of the activity of phenylethyl resorcinol against <italic>Microsporum Gypseum</italic></article-title><source>Molecule</source><year>2016</year><volume>21</volume><elocation-id>1306</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21101306</pub-id><?supplied-pmid 27706019?><pub-id pub-id-type="pmid">27706019</pub-id></element-citation></ref><ref id="B36-antibiotics-10-00592"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal&#x000e1;-Pa&#x000fa;l</surname><given-names>J.</given-names></name><name><surname>P&#x000e9;rez-Alonso</surname><given-names>M.J.</given-names></name><name><surname>Velasco-Negueruela</surname><given-names>A.</given-names></name></person-group><article-title>Volatile constituents isolated from the essential oil of <italic>Bupleurum rigidum</italic> ssp. <italic>paniculatum</italic> (Brot.) H. Wolff</article-title><source>J. Essent. Oil Res.</source><year>1999</year><volume>11</volume><fpage>456</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1080/10412905.1999.9701183</pub-id></element-citation></ref><ref id="B37-antibiotics-10-00592"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correia</surname><given-names>P.</given-names></name><name><surname>Canhoto</surname><given-names>J.M.</given-names></name><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title><italic>Bupleurum</italic> spp. in central Portugal: In vitro propagation and secretory ducts</article-title><source>Acta Hortic.</source><year>2015</year><volume>1083</volume><fpage>527</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.17660/ActaHortic.2015.1083.69</pub-id></element-citation></ref><ref id="B38-antibiotics-10-00592"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousefzadi</surname><given-names>M.</given-names></name><name><surname>Sonboli</surname><given-names>A.</given-names></name><name><surname>Ebrahimi</surname><given-names>S.N.</given-names></name><name><surname>Hashemi</surname><given-names>S.H.</given-names></name></person-group><article-title>Antimicrobial activity of essential oil and major constituents of Salvia chloroleuca</article-title><source>Z. Nat. C</source><year>2008</year><volume>63</volume><fpage>337</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1515/znc-2008-5-605</pub-id><?supplied-pmid 18669017?><pub-id pub-id-type="pmid">18669017</pub-id></element-citation></ref><ref id="B39-antibiotics-10-00592"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tampieri</surname><given-names>M.P.</given-names></name><name><surname>Galuppi</surname><given-names>R.</given-names></name><name><surname>Macchioni</surname><given-names>F.</given-names></name><name><surname>Carelle</surname><given-names>M.S.</given-names></name><name><surname>Falcioni</surname><given-names>L.</given-names></name><name><surname>Cioni</surname><given-names>P.L.</given-names></name><name><surname>Morelli</surname><given-names>I.</given-names></name></person-group><article-title>The inhibition of <italic>Candida albicans</italic> by selected essential oils and their major components</article-title><source>Mycopathologia</source><year>2005</year><volume>159</volume><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1007/s11046-003-4790-5</pub-id><pub-id pub-id-type="pmid">15883716</pub-id></element-citation></ref><ref id="B40-antibiotics-10-00592"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonboli</surname><given-names>A.</given-names></name><name><surname>Babakhani</surname><given-names>B.</given-names></name><name><surname>Mehrabian</surname><given-names>A.R.</given-names></name></person-group><article-title>Antimicrobial activity of six constituents of essential oil from Salvia</article-title><source>Z. Nat. C.</source><year>2006</year><volume>61</volume><fpage>160</fpage><lpage>164</lpage></element-citation></ref><ref id="B41-antibiotics-10-00592"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajput</surname><given-names>S.B.</given-names></name><name><surname>Karuppayil</surname><given-names>S.M.</given-names></name></person-group><article-title>Small molecules inhibit growth, viability and ergosterol biosynthesis in <italic>Candida albicans</italic></article-title><source>Springerplus</source><year>2013</year><volume>2</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/2193-1801-2-26</pub-id><pub-id pub-id-type="pmid">23449869</pub-id></element-citation></ref><ref id="B42-antibiotics-10-00592"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>E.</given-names></name><name><surname>Hrimpeng</surname><given-names>K.</given-names></name><name><surname>Lopes</surname><given-names>G.</given-names></name><name><surname>Vaz</surname><given-names>S.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M.J.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title>Antifungal activity of <italic>Ferulago capillaris</italic> essential oil against <italic>Candida</italic>, <italic>Cryptococcus</italic>, <italic>Aspergillus</italic> and dermatophyte species</article-title><source>Eur. J. Clin. Microbiol. Infect. Dis.</source><year>2013</year><volume>32</volume><fpage>1311</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1007/s10096-013-1881-1</pub-id><?supplied-pmid 23619574?><pub-id pub-id-type="pmid">23619574</pub-id></element-citation></ref><ref id="B43-antibiotics-10-00592"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname><given-names>T.</given-names></name><name><surname>Sugano</surname><given-names>M.</given-names></name><name><surname>Majid</surname><given-names>A.</given-names></name><name><surname>Fujii</surname><given-names>Y.</given-names></name></person-group><article-title>Antifungal effects of volatile compounds from black zira (<italic>Bunium persicum</italic>) and other spices and herbs</article-title><source>J. Chem. Ecol.</source><year>2007</year><volume>33</volume><fpage>2123</fpage><lpage>2132</lpage><pub-id pub-id-type="doi">10.1007/s10886-007-9374-2</pub-id><pub-id pub-id-type="pmid">17932718</pub-id></element-citation></ref><ref id="B44-antibiotics-10-00592"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leite</surname><given-names>A.M.</given-names></name><name><surname>de Oliveira Lima</surname><given-names>E.</given-names></name><name><surname>de Souza</surname><given-names>E.L.</given-names></name><name><surname>de F&#x000e1;tima Formiga Melo Diniz</surname><given-names>M.</given-names></name><name><surname>Trajano</surname><given-names>V.N.</given-names></name><name><surname>de Medeiros</surname><given-names>I.A.</given-names></name></person-group><article-title>Inhibitory effect of beta-pinene, alpha-pinene and eugenol on the growth of potential infectious endocarditis causing Gram-positive bacteria</article-title><source>Rev. Bras. Ci&#x000ea;ncias Farm.</source><year>2007</year><volume>43</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1590/S1516-93322007000100015</pub-id></element-citation></ref><ref id="B45-antibiotics-10-00592"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>K.A.</given-names></name><name><surname>Carson</surname><given-names>C.F.</given-names></name><name><surname>Riley</surname><given-names>T.V.</given-names></name></person-group><article-title>Antifungal activity of the components of <italic>Melaleuca alternifolia</italic> (tea tree) oil</article-title><source>J. Appl. Microbiol.</source><year>2003</year><volume>95</volume><fpage>853</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2003.02059.x</pub-id><?supplied-pmid 12969301?><pub-id pub-id-type="pmid">12969301</pub-id></element-citation></ref><ref id="B46-antibiotics-10-00592"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipowicz</surname><given-names>N.</given-names></name><name><surname>Kami&#x00144;ski</surname><given-names>M.</given-names></name><name><surname>Kurlenda</surname><given-names>J.</given-names></name><name><surname>Asztemborska</surname><given-names>M.</given-names></name><name><surname>Ochocka</surname><given-names>J.R.</given-names></name></person-group><article-title>Antibacterial and antifungal activity of juniper berry oil and its selected components</article-title><source>Phyther. Res.</source><year>2003</year><volume>17</volume><fpage>227</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1002/ptr.1110</pub-id><?supplied-pmid 12672151?><pub-id pub-id-type="pmid">12672151</pub-id></element-citation></ref><ref id="B47-antibiotics-10-00592"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halbandge</surname><given-names>S.D.</given-names></name><name><surname>Mortale</surname><given-names>S.P.</given-names></name><name><surname>Jadhav</surname><given-names>A.K.</given-names></name></person-group><article-title>Differential Sensitivities of various growth modes of <italic>Candida albicans</italic> to sixteen molecules of plant origin</article-title><source>J. Pharm. Phytochem.</source><year>2017</year><volume>6</volume><fpage>306</fpage><lpage>318</lpage></element-citation></ref><ref id="B48-antibiotics-10-00592"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raut</surname><given-names>J.S.</given-names></name><name><surname>Shinde</surname><given-names>R.B.</given-names></name><name><surname>Chauhan</surname><given-names>N.M.</given-names></name><name><surname>Mohan Karuppayil</surname><given-names>S.</given-names></name></person-group><article-title>Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by <italic>Candida albicans</italic></article-title><source>Biofouling</source><year>2013</year><volume>29</volume><fpage>87</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1080/08927014.2012.749398</pub-id><?supplied-pmid 23216018?><pub-id pub-id-type="pmid">23216018</pub-id></element-citation></ref><ref id="B49-antibiotics-10-00592"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname><given-names>E.</given-names></name><name><surname>Hidalgo-Bastida</surname><given-names>L.</given-names></name><name><surname>Verran</surname><given-names>J.</given-names></name><name><surname>Williams</surname><given-names>D.</given-names></name><name><surname>Malic</surname><given-names>S.</given-names></name></person-group><article-title>Antifungal activity of commercial essential oils and biocides against <italic>Candida albicans</italic></article-title><source>Pathogens</source><year>2018</year><volume>7</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens7010015</pub-id></element-citation></ref><ref id="B50-antibiotics-10-00592"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>C.</given-names></name><name><surname>Prados-Rosales</surname><given-names>R.</given-names></name><name><surname>Silva</surname><given-names>B.M.A.</given-names></name><name><surname>Nakouzi-Naranjo</surname><given-names>A.</given-names></name><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Chatterjee</surname><given-names>S.</given-names></name><name><surname>Stark</surname><given-names>R.E.</given-names></name><name><surname>Casadevall</surname><given-names>A.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>T.</given-names></name></person-group><article-title>Activation of melanin synthesis in <italic>Alternaria infectoria</italic> by antifungal drugs</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>60</volume><fpage>1646</fpage><lpage>1655</lpage><pub-id pub-id-type="doi">10.1128/AAC.02190-15</pub-id><?supplied-pmid 26711773?><pub-id pub-id-type="pmid">26711773</pub-id></element-citation></ref><ref id="B51-antibiotics-10-00592"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>M.L.</given-names></name><name><surname>Jimenez</surname><given-names>J.</given-names></name><name><surname>Ocete</surname><given-names>M.A.</given-names></name><name><surname>Zarzuelo</surname><given-names>A.</given-names></name><name><surname>Cabo</surname><given-names>M.M.</given-names></name></person-group><article-title>Comparative study of different essential oils of <italic>Bupleurum gibraltaricum</italic> Lamarck</article-title><source>Pharmazie</source><year>1989</year><volume>44</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">2772005</pub-id></element-citation></ref><ref id="B52-antibiotics-10-00592"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ocete</surname><given-names>M.A.</given-names></name><name><surname>Risco</surname><given-names>S.</given-names></name><name><surname>Zarzuelo</surname><given-names>A.</given-names></name><name><surname>Jimenez</surname><given-names>J.</given-names></name></person-group><article-title>Pharmacological activity of the essential oil of <italic>Bupleurum gibraltaricum</italic>: Anti-inflammatory activity and effects on isolated rat uteri</article-title><source>J. Ethnopharmacol.</source><year>1989</year><volume>25</volume><fpage>305</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(89)90036-6</pub-id><pub-id pub-id-type="pmid">2747263</pub-id></element-citation></ref><ref id="B53-antibiotics-10-00592"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cot&#x000e9;</surname><given-names>H.</given-names></name><name><surname>Boucher</surname><given-names>M.-A.</given-names></name><name><surname>Pichette</surname><given-names>A.</given-names></name><name><surname>Legault</surname><given-names>J.</given-names></name></person-group><article-title>Anti-inflammatory, antioxidant, antibiotic, and cytotoxic activities of <italic>Tanacetum vulgare</italic> L. essential oil and its constituents</article-title><source>Medicines</source><year>2017</year><volume>4</volume><elocation-id>34</elocation-id><pub-id pub-id-type="doi">10.3390/medicines4020034</pub-id></element-citation></ref><ref id="B54-antibiotics-10-00592"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rufino</surname><given-names>A.T.</given-names></name><name><surname>Ribeiro</surname><given-names>M.</given-names></name><name><surname>Sousa</surname><given-names>C.</given-names></name><name><surname>Judas</surname><given-names>F.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Mendes</surname><given-names>A.F.</given-names></name></person-group><article-title>Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis</article-title><source>Eur. J. Pharm.</source><year>2015</year><volume>750</volume><fpage>141</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.01.018</pub-id><?supplied-pmid 25622554?><pub-id pub-id-type="pmid">25622554</pub-id></element-citation></ref><ref id="B55-antibiotics-10-00592"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rufino</surname><given-names>A.T.</given-names></name><name><surname>Ribeiro</surname><given-names>M.</given-names></name><name><surname>Judas</surname><given-names>F.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name><name><surname>Lopes</surname><given-names>M.C.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Mendes</surname><given-names>A.F.</given-names></name></person-group><article-title>Anti-inflammatory and chondroprotective activity of (+)-&#x003b1;-pinene: Structural and enantiomeric selectivity</article-title><source>J. Nat. Prod.</source><year>2014</year><volume>77</volume><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1021/np400828x</pub-id><pub-id pub-id-type="pmid">24455984</pub-id></element-citation></ref><ref id="B56-antibiotics-10-00592"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrnh&#x000f6;fer-Ressler</surname><given-names>M.M.</given-names></name><name><surname>Fricke</surname><given-names>K.</given-names></name><name><surname>Pignitter</surname><given-names>M.</given-names></name><name><surname>Walker</surname><given-names>J.M.</given-names></name><name><surname>Walker</surname><given-names>J.</given-names></name><name><surname>Rychlik</surname><given-names>M.</given-names></name><name><surname>Somoza</surname><given-names>V.</given-names></name></person-group><article-title>Identification of 1,8-cineole, borneol, camphor, and thujone as anti-inflammatory compounds in a <italic>Salvia officinalis</italic> L. infusion using human gingival fibroblasts</article-title><source>J. Agric. Food Chem.</source><year>2013</year><volume>61</volume><fpage>3451</fpage><lpage>3459</lpage><pub-id pub-id-type="doi">10.1021/jf305472t</pub-id><?supplied-pmid 23488631?><pub-id pub-id-type="pmid">23488631</pub-id></element-citation></ref><ref id="B57-antibiotics-10-00592"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lima</surname><given-names>V.T.</given-names></name><name><surname>Vieira</surname><given-names>M.C.</given-names></name><name><surname>Kassuya</surname><given-names>C.A.L.</given-names></name><name><surname>Cardoso</surname><given-names>C.A.L.</given-names></name><name><surname>Alves</surname><given-names>J.M.</given-names></name><name><surname>Foglio</surname><given-names>M.A.</given-names></name><name><surname>de Carvalho</surname><given-names>J.E.</given-names></name><name><surname>Formagio</surname><given-names>A.S.N.</given-names></name></person-group><article-title>Chemical composition and free radical-scavenging, anticancer and anti-inflammatory activities of the essential oil from <italic>Ocimum kilimandscharicum</italic></article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><fpage>1298</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2014.07.004</pub-id><pub-id pub-id-type="pmid">25172793</pub-id></element-citation></ref><ref id="B58-antibiotics-10-00592"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramalho</surname><given-names>T.</given-names></name><name><surname>Pacheco de Oliveira</surname><given-names>M.</given-names></name><name><surname>Lima</surname><given-names>A.</given-names></name><name><surname>Bezerra-Santos</surname><given-names>C.</given-names></name><name><surname>Piuvezam</surname><given-names>M.</given-names></name></person-group><article-title>Gamma-terpinene modulates acute inflammatory response in mice</article-title><source>Planta Med.</source><year>2015</year><volume>81</volume><fpage>1248</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1055/s-0035-1546169</pub-id><?supplied-pmid 26132854?><pub-id pub-id-type="pmid">26132854</pub-id></element-citation></ref><ref id="B59-antibiotics-10-00592"><label>59.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Council of Europe</collab></person-group><source>European Pharmacopoeia</source><edition>9th ed.</edition><publisher-name>Council of Europe</publisher-name><publisher-loc>Strasbourg, France</publisher-loc><year>2016</year></element-citation></ref><ref id="B60-antibiotics-10-00592"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marichal</surname><given-names>P.</given-names></name><name><surname>Gorrens</surname><given-names>J.</given-names></name><name><surname>Cutsem</surname><given-names>J.</given-names></name><name><surname>Bossche</surname><given-names>H.</given-names></name></person-group><article-title>Vanden Culture media for the study of the effects of azole derivatives on germ tube formation and hyphal growth of C. albicans/N&#x000e4;hrb&#x000f6;den zur Untersuchung der Wirkungen von Azolderivaten auf die Keimschlauchbildung und das Hyphenwachstum bei C. albicans</article-title><source>Mycoses</source><year>2009</year><volume>29</volume><fpage>76</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1111/j.1439-0507.1986.tb03753.x</pub-id></element-citation></ref><ref id="B61-antibiotics-10-00592"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>M.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M.J.</given-names></name><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Alves-Silva</surname><given-names>J.M.</given-names></name><name><surname>Cavaleiro</surname><given-names>C.</given-names></name><name><surname>Cruz</surname><given-names>M.T.</given-names></name><name><surname>Salgueiro</surname><given-names>L.</given-names></name></person-group><article-title>Unveiling the antifungal potential of two Iberian thyme essential oils: Effect on <italic>C. albicans</italic> germ tube and preformed biofilms</article-title><source>Front. Pharm.</source><year>2019</year><volume>10</volume><pub-id pub-id-type="doi">10.3389/fphar.2019.00446</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="antibiotics-10-00592-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Filamentation percentage of <italic>Candida albicans</italic> ATCC 10231 treated with different concentrations of <italic>Bupleurum rigidum</italic> subp. <italic>paniculatum</italic> essential oil (<bold>a</bold>) or treated with fluconazole (<bold>b</bold>). One-way ANOVA followed by Dunnett&#x02019;s Multiple Comparison Test, ** <italic>p</italic> &#x0003c; 0.01; *** <italic>p</italic> &#x0003c; 0.001, compared to control.</p></caption><graphic xlink:href="antibiotics-10-00592-g001"/></fig><fig id="antibiotics-10-00592-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effect of <italic>Bupleurum rigidum</italic> subp. <italic>paniculatum</italic> essential oil (<bold>a</bold>) and fluoconazole (<bold>b</bold>) on <italic>Candida albicans</italic> ATCC 10231 biofilm biomass and viability. One-way ANOVA followed by Dunnett&#x02019;s multiple comparison test (performed in separate on each feature), * <italic>p</italic> &#x0003c; 0.05, compared to biofilm mass control; # <italic>p</italic> &#x0003c; 0.05 and ## <italic>p</italic> &#x0003c; 0.01, compared to biofilm viability control; arrows indicate MIC value.</p></caption><graphic xlink:href="antibiotics-10-00592-g002"/></fig><fig id="antibiotics-10-00592-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Transmission electron microscopic observations of <italic>Candida albicans</italic> in the presence of DMSO (<bold>a</bold>,<bold>b</bold>) or treated with of 72 &#x000b5;g/mL of <italic>Bupleurum rigidum</italic> subsp. <italic>paniculatum</italic> essential oil (<bold>c</bold>&#x02013;<bold>h</bold>). Arrow points to fragments from the cell wall; c&#x02014;cell wall.</p></caption><graphic xlink:href="antibiotics-10-00592-g003"/></fig><fig id="antibiotics-10-00592-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Transmission electron microscopic observations of <italic>Trichophyton rubrum</italic> in the presence of DMSO (<bold>a</bold>,<bold>b</bold>) or treated with of 576 &#x000b5;g/mL of <italic>Bupleurum rigidum</italic> subsp. <italic>paniculatum</italic> essential oil (<bold>c</bold>&#x02013;<bold>h</bold>). Arrow points to fragments from the cell wall; * shows an autophagic structure; c&#x02014;cell wall, v&#x02014;vacuoles.</p></caption><graphic xlink:href="antibiotics-10-00592-g004"/></fig><fig id="antibiotics-10-00592-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Effect of <italic>Bupleurum rigidum</italic> subp. <italic>paniculatum</italic> essential oil on NO production (<bold>a</bold>) and cell viability (<bold>b</bold>). One-way ANOVA followed by Dunnett&#x02019;s Multiple Comparison Test, ### <italic>p</italic> &#x0003c; 0.001, compared to control; ** <italic>p</italic> &#x0003c; 0.01; *** <italic>p</italic> &#x0003c; 0.001, compared to LPS. EO&#x02014;essential oil.</p></caption><graphic xlink:href="antibiotics-10-00592-g005"/></fig><table-wrap id="antibiotics-10-00592-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-10-00592-t001_Table 1</object-id><label>Table 1</label><caption><p>Chemical composition of Portuguese <italic>Bupleurum rigidum</italic> subsp. <italic>paniculatum</italic> essential oil.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound *</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RI<break/>SPB-1 <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RI<break/>SW 10 <sup>b</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coimbra<break/>(%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">F&#x000e1;tima<break/>(%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Thujene</td><td align="center" valign="middle" rowspan="1" colspan="1">922</td><td align="center" valign="middle" rowspan="1" colspan="1">1029</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">930</td><td align="center" valign="middle" rowspan="1" colspan="1">1030</td><td align="center" valign="middle" rowspan="1" colspan="1">36.0</td><td align="center" valign="middle" rowspan="1" colspan="1">29.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Camphene</td><td align="center" valign="middle" rowspan="1" colspan="1">943</td><td align="center" valign="middle" rowspan="1" colspan="1">1077</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fenchene</td><td align="center" valign="middle" rowspan="1" colspan="1">943</td><td align="center" valign="middle" rowspan="1" colspan="1">1067</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sabinene</td><td align="center" valign="middle" rowspan="1" colspan="1">964</td><td align="center" valign="middle" rowspan="1" colspan="1">1128</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0</td><td align="center" valign="middle" rowspan="1" colspan="1">2.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-Pinene</td><td align="center" valign="middle" rowspan="1" colspan="1">970</td><td align="center" valign="middle" rowspan="1" colspan="1">1118</td><td align="center" valign="middle" rowspan="1" colspan="1">26.1</td><td align="center" valign="middle" rowspan="1" colspan="1">30.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Myrcene</td><td align="center" valign="middle" rowspan="1" colspan="1">981</td><td align="center" valign="middle" rowspan="1" colspan="1">1160</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" rowspan="1" colspan="1">10.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Phellandrene</td><td align="center" valign="middle" rowspan="1" colspan="1">997</td><td align="center" valign="middle" rowspan="1" colspan="1">1171</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Terpinene</td><td align="center" valign="middle" rowspan="1" colspan="1">1006</td><td align="center" valign="middle" rowspan="1" colspan="1">1183</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic>-Cymene</td><td align="center" valign="middle" rowspan="1" colspan="1">1009</td><td align="center" valign="middle" rowspan="1" colspan="1">1271</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="center" valign="middle" rowspan="1" colspan="1">1021</td><td align="center" valign="middle" rowspan="1" colspan="1">1204</td><td align="center" valign="middle" rowspan="1" colspan="1">10.5</td><td align="center" valign="middle" rowspan="1" colspan="1">13.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-Phellandrene</td><td align="center" valign="middle" rowspan="1" colspan="1">1021</td><td align="center" valign="middle" rowspan="1" colspan="1">1214</td><td align="center" valign="middle" rowspan="1" colspan="1">9.4</td><td align="center" valign="middle" rowspan="1" colspan="1">4.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Z-&#x003b2;-Ocimene</td><td align="center" valign="middle" rowspan="1" colspan="1">1025</td><td align="center" valign="middle" rowspan="1" colspan="1">1235</td><td align="center" valign="middle" rowspan="1" colspan="1">4.1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>E</italic>-&#x003b2;-Ocimene</td><td align="center" valign="middle" rowspan="1" colspan="1">1035</td><td align="center" valign="middle" rowspan="1" colspan="1">1253</td><td align="center" valign="middle" rowspan="1" colspan="1">5.1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b3;-Terpinene</td><td align="center" valign="middle" rowspan="1" colspan="1">1046</td><td align="center" valign="middle" rowspan="1" colspan="1">1249</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Terpinolene</td><td align="center" valign="middle" rowspan="1" colspan="1">1076</td><td align="center" valign="middle" rowspan="1" colspan="1">1288</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Monoterpene hydrocarbons</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">96.6</td><td align="center" valign="middle" rowspan="1" colspan="1">94.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Linalool</td><td align="center" valign="middle" rowspan="1" colspan="1">1082</td><td align="center" valign="middle" rowspan="1" colspan="1">1543</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Pinene-xide</td><td align="center" valign="middle" rowspan="1" colspan="1">1077</td><td align="center" valign="middle" rowspan="1" colspan="1">1370</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>allo-</italic>Ocimene</td><td align="center" valign="middle" rowspan="1" colspan="1">1118</td><td align="center" valign="middle" rowspan="1" colspan="1">1370</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Terpinene-4-ol</td><td align="center" valign="middle" rowspan="1" colspan="1">1159</td><td align="center" valign="middle" rowspan="1" colspan="1">1595</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Myrtenal</td><td align="center" valign="middle" rowspan="1" colspan="1">1176</td><td align="center" valign="middle" rowspan="1" colspan="1">1786</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Terpineol</td><td align="center" valign="middle" rowspan="1" colspan="1">1168</td><td align="center" valign="middle" rowspan="1" colspan="1">1692</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bornyl acetate</td><td align="center" valign="middle" rowspan="1" colspan="1">1266</td><td align="center" valign="middle" rowspan="1" colspan="1">1578</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Oxygen containing monoterpenes</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Copaene</td><td align="center" valign="middle" rowspan="1" colspan="1">1364</td><td align="center" valign="middle" rowspan="1" colspan="1">1487</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-Cubebene</td><td align="center" valign="middle" rowspan="1" colspan="1">1380</td><td align="center" valign="middle" rowspan="1" colspan="1">1538</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>E</italic>-Caryophyllene</td><td align="center" valign="middle" rowspan="1" colspan="1">1408</td><td align="center" valign="middle" rowspan="1" colspan="1">1590</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b3;-Elemene</td><td align="center" valign="middle" rowspan="1" colspan="1">1417</td><td align="center" valign="middle" rowspan="1" colspan="1">2136</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Humulene</td><td align="center" valign="middle" rowspan="1" colspan="1">1442</td><td align="center" valign="middle" rowspan="1" colspan="1">1665</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Germacrene-D</td><td align="center" valign="middle" rowspan="1" colspan="1">1466</td><td align="center" valign="middle" rowspan="1" colspan="1">1699</td><td align="center" valign="middle" rowspan="1" colspan="1">1.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Bicyclogermacrene</td><td align="center" valign="middle" rowspan="1" colspan="1">1478</td><td align="center" valign="middle" rowspan="1" colspan="1">1727</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b4;-Cadinene</td><td align="center" valign="middle" rowspan="1" colspan="1">1508</td><td align="center" valign="middle" rowspan="1" colspan="1">1751</td><td align="center" valign="middle" rowspan="1" colspan="1">0,1</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>Sesquiterpene hydrocarbons</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Spathulenol</td><td align="center" valign="middle" rowspan="1" colspan="1">1551</td><td align="center" valign="middle" rowspan="1" colspan="1">2112</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Caryophyllene oxide</td><td align="center" valign="middle" rowspan="1" colspan="1">1557</td><td align="center" valign="middle" rowspan="1" colspan="1">1968</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td><td align="center" valign="middle" rowspan="1" colspan="1">t</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Oxygen containing sesquiterpenes</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Total identified</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.6</td></tr></tbody></table><table-wrap-foot><fn><p>* Compounds listed in order of elution in the SPB-1 column; t &#x0003c; 0.05%. <sup>a</sup> RI SPB 1: GC retention indices relative to C9-C23 n-alkanes on the SPB-1 column. <sup>b</sup> RI SW 10: GC retention indices relative to C9-C23 n-alkanes on the Supelcowax-10 column.</p></fn></table-wrap-foot></table-wrap><table-wrap id="antibiotics-10-00592-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-10-00592-t002_Table 2</object-id><label>Table 2</label><caption><p>Antifungal activity of <italic>Bupleurum rigidum</italic> subsp. <italic>paniculatum</italic> essential oil.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Strains</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Essential Oil</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Fluconazole</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIC</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MLC</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIC</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MLC</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Candida albicans</italic> ATCC 10231</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Candida tropicalis</italic> ATCC 13803</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1125</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1125</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Candida krusei</italic> H9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64&#x02013;128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Candida guillermondii</italic> MAT23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Candida parapsilosis</italic> ATCC 90018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cryptococcus neoformans</italic> CECT 1078</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">144</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Trichophytum mentagrophytes</italic> FF7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16&#x02013;32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32&#x02013;64</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Trichophytum mentagrophytes</italic> var. <italic>interdigitale</italic> CECT 2958</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Trichophyton rubrum</italic> CECT 2794</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Trichophytum verrucosum</italic> CECT 2992</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Microsporum canis</italic> FF1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">144</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">144</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Microsporum gypseum</italic> CECT 2905</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;128</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Epidermophyton floccosum</italic> FF9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">144</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">144</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aspergillus niger</italic> ATCC 16404</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1125</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.t</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.t</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aspergillus fumigatus</italic> ATCC 46645</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.t</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.t</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Aspergillus flavus</italic> F44</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">576</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.t</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n.t</td></tr></tbody></table><table-wrap-foot><fn><p>MIC&#x02014;minimal inhibitory concentration and MLC&#x02014;minimal lethal concentration determined by a macrodilution method and expressed as &#x000b5;g/mL; n.t&#x02014;not tested.</p></fn></table-wrap-foot></table-wrap></floats-group></article>